Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication

Arch Bronconeumol. 2017 Apr;53(4):213-215. doi: 10.1016/j.arbres.2016.08.010. Epub 2016 Oct 15.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Colorectal Neoplasms / drug therapy
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Humans
  • Leucovorin / administration & dosage
  • Leucovorin / adverse effects
  • Lung Diseases, Interstitial / chemically induced*
  • Male
  • Middle Aged
  • Organoplatinum Compounds / administration & dosage
  • Organoplatinum Compounds / adverse effects*
  • Oxaliplatin

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • Folfox protocol